Skip to main content
. Author manuscript; available in PMC: 2016 Sep 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2015 Jun 29;287(3):299–305. doi: 10.1016/j.taap.2015.06.017

Fig. 1. Effect of Thymoquinone on human RA-FLS viability.

Fig. 1

RA-FLS were treated with (A) Thymoquinone (TQ) (0.1–5 μM) for 24 hrs; (B) TQ (1–5 μM) with or without TNF-α (20 ng/ml).